Sean Brynjelsen - Feb 13, 2024 Form 4 Insider Report for Eton Pharmaceuticals, Inc. (ETON)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ETON	Stock Option (Right to buy)	Award	$0	+439K	+21.56%	$0.00	2.47M	Feb 13, 2024	Common Stock	439K	$4.42	Direct	F1

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The shares subject to the option shall vest in 48 equal monthly installments from the date of grant until fully vested and exercisable on February 13, 2028.

The reporting person has authorized and designated the named person to file this Form 4 on the reporting person's behalf for indefinite duration.